Dr. James Peyer is founder and CEO of Cambrian Bio. James has spent two decades working to bring the first longevity drug to market. In this time, he’s brought over $500M into the field as a whole, and now has multiple drugs in clinical trials that could plausibly prove to be… the first true longevity drugs, or gerotherapeutics.In today’s episode, we dive into the history of the geroscience field. We discuss what makes geroscience’s approach to drug development so unique, how to unlock the flywheel of innovation that will get us longevity escape velocity, and Amplifier Therapeutics' “zone 2 in a pill”... which might prove to be the first ever true, longevity drug.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Aging kills EVERYONE, but only because we're not trying hard enough - Longevity Activist Nathan Cheng
The one-man biotech is only 10 years away - a16z-backed founder Kexin Huang
These 30-something Harvard Professors are making biology programmable - AbuGoot Lab
Longevity politics with the Forbes 30U30 lobbyist changing DC - Dylan Livingston, A4LI
Free AI-powered recaps of Free Radicals and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.